Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-06-26

Clinical Trial Update: Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema [NA]

View source ↗

Summary

A clinical trial evaluating intravenous galactose for diabetic macular edema was terminated; no results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galactose (intravenous) (galactose)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Diabetic Macular Oedema | NA | Status: TERMINATED